denkapparat Operations GmbH Makes New $309,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

denkapparat Operations GmbH acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 1,028 shares of the company's stock, valued at approximately $309,000.

A number of other large investors have also bought and sold shares of the stock. Congress Wealth Management LLC DE boosted its holdings in HCA Healthcare by 3.4% in the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after acquiring an additional 34 shares in the last quarter. Evergreen Private Wealth LLC grew its position in HCA Healthcare by 0.3% in the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after purchasing an additional 35 shares during the period. Mediolanum International Funds Ltd lifted its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock valued at $3,153,000 after buying an additional 36 shares in the last quarter. Prairie Wealth Advisors Inc. raised its holdings in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock worth $210,000 after acquiring an additional 40 shares during the last quarter. Finally, Whittier Trust Co. increased its holdings in HCA Healthcare by 3.6% during the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after purchasing an additional 41 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 0.2 %

Shares of HCA stock traded up $0.59 during mid-day trading on Tuesday, reaching $346.14. The stock had a trading volume of 308,415 shares, compared to its average volume of 1,342,767. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $85.22 billion, a PE ratio of 15.74, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The stock's 50-day moving average price is $325.24 and its two-hundred day moving average price is $340.60.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the business posted $5.90 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date was Monday, March 17th. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio (DPR) is 13.11%.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of several recent analyst reports. JPMorgan Chase & Co. restated a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Barclays dropped their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research report on Monday, January 27th. Bank of America dropped their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a report on Monday, January 27th. Truist Financial lowered their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, Cantor Fitzgerald restated an "overweight" rating and issued a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.